Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Morrison

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
BMJ Open|August 17, 2025
Real-world waitlist randomised controlled trial of gameChange VR to treat severe agoraphobic avoidance in patients with psychosis: a study protocolDaniel Freeman, Julia Jones, Eloise Prouten, et al.
Schizophrenia Research|January 1, 2014
Pathways to care in subjects at high risk for psychotic disorders - a European perspectiveHeinrich Graf von Reventlow, Seza Krüger-Özgürdal, Stephan Ruhrmann, et al.
Trials|May 23, 2022
Multisite randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trialEmmanuelle Peters, Amy Hardy, Robert Dudley, et al.
Schizophrenia Research|November 7, 2022
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trialDaniel Freeman, Sinéad Lambe, Ushma Galal, et al.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Psychological Medicine|April 3, 2023
The Oxford Agoraphobic Avoidance ScaleSinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
Behavioural and Cognitive Psychotherapy|February 15, 2022
Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)Laina Rosebrock, Sinéad Lambe, Sophie Mulhall, et al.
Psychological Medicine|April 28, 2022
Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effectsDaniel Freeman, Laina Rosebrock, Felicity Waite, et al.
Archives of Pathology & Laboratory Medicine|December 12, 2025
Challenges in Structuring SARS-CoV-2 Emergency Use Authorization Diagnostics Data: Leveraging Findable, Accessible, Interoperable, and Reusable Principles for the Next Era of Diagnostic Data TransparencyAlexander J Phillips, Aaron L Glieberman, Christina Gallegos, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
BMJ Open|August 17, 2025
Real-world waitlist randomised controlled trial of gameChange VR to treat severe agoraphobic avoidance in patients with psychosis: a study protocolDaniel Freeman, Julia Jones, Eloise Prouten, et al.
Schizophrenia Research|January 1, 2014
Pathways to care in subjects at high risk for psychotic disorders - a European perspectiveHeinrich Graf von Reventlow, Seza Krüger-Özgürdal, Stephan Ruhrmann, et al.
Trials|May 23, 2022
Multisite randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trialEmmanuelle Peters, Amy Hardy, Robert Dudley, et al.
Schizophrenia Research|November 7, 2022
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trialDaniel Freeman, Sinéad Lambe, Ushma Galal, et al.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Psychological Medicine|April 3, 2023
The Oxford Agoraphobic Avoidance ScaleSinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
Behavioural and Cognitive Psychotherapy|February 15, 2022
Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)Laina Rosebrock, Sinéad Lambe, Sophie Mulhall, et al.
Psychological Medicine|April 28, 2022
Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effectsDaniel Freeman, Laina Rosebrock, Felicity Waite, et al.
Archives of Pathology & Laboratory Medicine|December 12, 2025
Challenges in Structuring SARS-CoV-2 Emergency Use Authorization Diagnostics Data: Leveraging Findable, Accessible, Interoperable, and Reusable Principles for the Next Era of Diagnostic Data TransparencyAlexander J Phillips, Aaron L Glieberman, Christina Gallegos, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Pageof 6